ATE156119T1 - 2-FORMYLPYRIDINE THIOSEMICARBAZONE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS ANTITUMOR AGENTS - Google Patents
2-FORMYLPYRIDINE THIOSEMICARBAZONE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS ANTITUMOR AGENTSInfo
- Publication number
- ATE156119T1 ATE156119T1 AT93401234T AT93401234T ATE156119T1 AT E156119 T1 ATE156119 T1 AT E156119T1 AT 93401234 T AT93401234 T AT 93401234T AT 93401234 T AT93401234 T AT 93401234T AT E156119 T1 ATE156119 T1 AT E156119T1
- Authority
- AT
- Austria
- Prior art keywords
- hydrogen
- preparation
- antitumor agents
- lower alkyl
- thiosemicarbazone derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/73—Unsubstituted amino or imino radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/61—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/65—One oxygen atom attached in position 3 or 5
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/76—Nitrogen atoms to which a second hetero atom is attached
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
The invention discloses the use of an active compound of the formula : <CHEM> wherein : either <a) R<1> is NHR<4>, NR<4>R<5> or OH and R<3> is hydrogen or <b) R<3> is NHR<4>, NR<4>R<5> or OH and R<1> is hydrogen ; R<2> is hydrogen or C1-4 lower alkyl ; R<4> is hydrogen, hydroxyl or C1-4 lower alkyl ; and R<5> is C1-4 lower alkyl ; provided that when R<1> is OH, R<2> is methyl, and provided that when R<3> is N(CH3)2 or OH, R<1> and R<2> cannot both be hydrogen or a pharmaceutically acceptable salt or hydrate thereof for the manufacture of a medicament for treating a tumor in a mammal, as well as new compounds, of the formula (I) except the compound wherein R<1> is OH, R<2> is methyl and R<3> is hydrogen and the corresponding pharmaceutical composition.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/882,154 US5281715A (en) | 1992-05-13 | 1992-05-13 | 2-formylpyridine thiosemicarbazone compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE156119T1 true ATE156119T1 (en) | 1997-08-15 |
Family
ID=25379994
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT93401234T ATE156119T1 (en) | 1992-05-13 | 1993-05-13 | 2-FORMYLPYRIDINE THIOSEMICARBAZONE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS ANTITUMOR AGENTS |
Country Status (9)
Country | Link |
---|---|
US (2) | US5281715A (en) |
EP (1) | EP0570294B1 (en) |
JP (1) | JP3192027B2 (en) |
AT (1) | ATE156119T1 (en) |
CA (1) | CA2095881C (en) |
DE (1) | DE69312567T2 (en) |
DK (1) | DK0570294T3 (en) |
ES (1) | ES2108240T3 (en) |
GR (1) | GR3025207T3 (en) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2065299C1 (en) * | 1994-07-15 | 1996-08-20 | Акционерное общество закрытого типа "Олвик" | Nootropic and tranquilizing agent |
US5767134A (en) * | 1997-05-15 | 1998-06-16 | Vion Pharmaceuticals, Inc. | Prodrug forms of ribonucleotide reductase inhibitors 3-AP and 3-AMP |
US6040338A (en) * | 1997-11-03 | 2000-03-21 | Yale University | N,n-bis(sulfonyl)hydrazines useful as antineoplastic agents |
CA2525298A1 (en) * | 2003-05-01 | 2004-11-18 | Panacea Pharmaceuticals, Inc. | Methods of treating ischemic related conditions |
CA2527799A1 (en) * | 2003-05-30 | 2004-12-16 | Merck & Co., Inc. | Methods for identifying modulators of kinesin activity |
US20060194810A1 (en) * | 2004-04-30 | 2006-08-31 | Bijan Almassian | Methods of treating ischemic related conditions |
US20090298891A1 (en) * | 2005-09-16 | 2009-12-03 | Government Of The Us, As Represented By The Secretady Of Health And Human Services | Methods of Treating or Preventing Cancer Using Pyridine Carboxaldehyde Pyridine Thiosemicarbazone Radiosensitizing Agents |
MD4126C1 (en) * | 2010-11-15 | 2012-04-30 | Государственный Университет Молд0 | N,N'-[4,4'-(perfluoro-1,4-phenylenedioxy)-bis(4,1-phenylene)]-bis[2-(pyridine-2-ilmethylene)hydrazinecarbothioamide] and use thereof as prostate cancer LNCaP cell proliferation inhibitor |
US20140271812A1 (en) * | 2013-03-14 | 2014-09-18 | Panacea Pharmaceuticals | Treatment for chemotherapy-induced cognitive impairment |
US20140287021A1 (en) | 2013-03-21 | 2014-09-25 | Panacea Pharmaceuticals | Treatment of chemotherapy-induced peripheral neuropathy |
MD4349C1 (en) * | 2014-06-23 | 2015-12-31 | Государственный Университет Молд0 | N-(3-methoxyphenyl)-2-(pyridine-2-ylmethylene)-hydrazinecarbothioamide compound - inhibitor of human melanoma MeW-164 cell proliferation |
MD4407C1 (en) * | 2015-04-29 | 2016-10-31 | Государственный Университет Молд0 | Inhibitor of human myeloid leukemia HL-60 cells based on bis[N-(prop-2-en-1-yl)-2-(pyridine-2-ylmethylidene)hydrazinecarbothioamide]nickel(II) chloride hydrate |
MD4393C1 (en) * | 2015-09-04 | 2016-08-31 | Государственный Университет Молд0 | Inhibitor of human myeloid leukemia HL-60 cells based on nitrato-[N′-(1-pyridine-2-ylmethylidene)-morpholine-4-carbothiohydrazido(1-)]copper |
MD4434C1 (en) * | 2015-10-09 | 2017-04-30 | Государственный Университет Молд0 | Use of N'-[1-(2-pyridyl)ethylidene]morpholin-4-carbothiohydrazide as a human myeloid leukemia HL-60 cell proliferation inhibitor |
MD4520C1 (en) * | 2016-12-16 | 2018-05-31 | Государственный Университет Молд0 | N-(4-butoxyphenyl)-2-(pyridin-2-ylmethylidene)hydrazinecarbothioamide as T-47D breast cancer cells growth inhibitor |
CN109265453A (en) * | 2018-10-23 | 2019-01-25 | 华侨大学 | It is a kind of as the semicarbazones analog derivative of caspase-3 activator and its application |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8320308D0 (en) * | 1983-07-28 | 1983-09-01 | Wellcome Found | Antiviral combinations |
-
1992
- 1992-05-13 US US07/882,154 patent/US5281715A/en not_active Expired - Lifetime
-
1993
- 1993-05-10 CA CA002095881A patent/CA2095881C/en not_active Expired - Fee Related
- 1993-05-13 ES ES93401234T patent/ES2108240T3/en not_active Expired - Lifetime
- 1993-05-13 EP EP93401234A patent/EP0570294B1/en not_active Expired - Lifetime
- 1993-05-13 DK DK93401234.5T patent/DK0570294T3/en active
- 1993-05-13 DE DE69312567T patent/DE69312567T2/en not_active Expired - Fee Related
- 1993-05-13 JP JP11196393A patent/JP3192027B2/en not_active Expired - Fee Related
- 1993-05-13 AT AT93401234T patent/ATE156119T1/en not_active IP Right Cessation
-
1996
- 1996-08-22 US US08/701,566 patent/US5721259A/en not_active Expired - Lifetime
-
1997
- 1997-10-29 GR GR970402844T patent/GR3025207T3/en unknown
Also Published As
Publication number | Publication date |
---|---|
CA2095881A1 (en) | 1993-11-14 |
ES2108240T3 (en) | 1997-12-16 |
DE69312567D1 (en) | 1997-09-04 |
JPH06128230A (en) | 1994-05-10 |
DE69312567T2 (en) | 1998-03-19 |
GR3025207T3 (en) | 1998-02-27 |
US5281715A (en) | 1994-01-25 |
EP0570294A1 (en) | 1993-11-18 |
EP0570294B1 (en) | 1997-07-30 |
US5721259A (en) | 1998-02-24 |
CA2095881C (en) | 2002-01-22 |
DK0570294T3 (en) | 1998-02-02 |
JP3192027B2 (en) | 2001-07-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE156119T1 (en) | 2-FORMYLPYRIDINE THIOSEMICARBAZONE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS ANTITUMOR AGENTS | |
ATE247654T1 (en) | NEW HETEROCYCLIC COMPOUNDS | |
KR940007270B1 (en) | Quinazoline derivatives | |
DE69811329D1 (en) | Imidazolidin-4-one derivatives can be used as anti-cancer agents | |
ATE289602T1 (en) | QUINOLIN-2-ONE DERIVATIVES USABLE AS ANTI-CANCER AGENT | |
MA23639A1 (en) | PYRROCARBAZOLE DERIVATIVES, THEIR PREPARATION, THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, THEIR USE IN THE TREATMENT OF MALIGNANT TUMORS. | |
ATE81655T1 (en) | CEPHEM COMPOUNDS AND PROCESSES FOR THEIR PRODUCTION. | |
KR880007462A (en) | Propiophenone Derivatives for the Treatment of Frequency | |
MX9206930A (en) | NEW COMPOUNDS | |
ATE160566T1 (en) | AMPHOTERELIC TRICYCLIC COMPOUNDS AS ANTHISTAMINIC AND ANTIALLERGIC AGENTS | |
DK0420224T3 (en) | Anthihepatopathic remedy | |
ATE29133T1 (en) | TROPONONE DERIVATIVES, PROCESS FOR THEIR MANUFACTURE AND PHARMACEUTICAL COMPOSITION CONTAINING THEM. | |
ATE21908T1 (en) | 1,4-DIAMINOCYCLITOL DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. | |
ATE109003T1 (en) | THERAPEUTIC AGENT AGAINST POLLAKIURIA, URINE URICNESS OR INCONTINENCE CONTAINING ALPHA-PHENYL-ALPHA-PYRIDYLALKAN CARBONIC ACID DERIVATIVES. | |
HK34095A (en) | Use of 2-oxo-imidazolidine derivatives in the treatment of kidney diseases | |
HRP940361A2 (en) | Pharmaceutical preparations for the prevention and/or treatment of gastrointestinal deseases including ulcus |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification | ||
REN | Ceased due to non-payment of the annual fee |